Jacobs bags contract for Bristol-Myers Squibb's biologics plant

Jacobs Engineering Group Inc has received a contract from Bristol-Myers Squibb Company to provide construction management services for a new large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland.
 
Jacobs will also provide architectural and engineering services for the facility, which is being built to produce multiple therapies for the company’s robust and growing portfolio of approved and investigational biologic medicines, and to increase Bristol-Myers Squibb’s biologics manufacturing capacity. The facility is estimated to be operational in 2019.
 
The new facility is expected to include multiple large scale bioreactors, a purification area, as well as office and laboratory space. Bristol-Myers Squibb’s Board of Directors has approved initial funding that will support the first phase of the project, with the full cost of the facility expected to be finalized in the second half of 2015.
 
Chris Nagel, group vice president, Jacobs, stated, “We are excited to provide construction management services to Bristol-Myers Squibb, especially since our team is already mobilised and engaged in this project. The continuity and knowledge we bring, having already provided architectural and engineering services, is a tremendous benefit in bringing this project to fruition.”